Weaver C. Barksdale & Associates, Inc. Abb Vie Inc. Transaction History

Weaver C. Barksdale & Associates, Inc.

$111 Million
Q3 2024

A detailed history of Weaver C. Barksdale & Associates, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Weaver C. Barksdale & Associates, Inc. holds 11,712 shares of ABBV stock, worth $2.06 Million. This represents 2.09% of its overall portfolio holdings.

Number of Shares

11,712

Previous 12,143 3.55%

Holding current value

$2.06 Million

Previous $2.08 Million 11.05%

% of portfolio

2.09%

Previous 1.98%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $70,615 - $85,911	-431 Reduced 3.55%	11,712 $2.31 Million
Q2 2024 Aug 12, 2024	SELL	$154.79 - $180.76 $29,255 - $34,163	-189 Reduced 1.53%	12,143 $2.08 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $15,502 - $17,663	-97 Reduced 0.78%	12,332 $2.25 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $429,449 - $483,661	-3,121 Reduced 20.07%	12,429 $1.93 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $345,730 - $400,234	2,588 Added 19.97%	15,550 $2.32 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $104,285 - $129,776	-787 Reduced 5.72%	12,962 $1.75 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $96,599 - $111,248	-668 Reduced 4.63%	13,749 $2.19 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $50,206 - $60,210	363 Added 2.58%	14,417 $2.33 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $66,836 - $76,657	-498 Reduced 3.42%	14,054 $1.89 Million
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $475,752 - $604,836	-3,457 Reduced 19.2%	14,552 $2.23 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $32,863 - $40,773	249 Added 1.4%	18,009 $2.92 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $392,549 - $496,688	-3,654 Reduced 17.06%	17,760 $2.41 Million
Q4 2017 Jan 10, 2018	SELL	$89.56 - $98.21 $62,154 - $68,157	-694 Reduced 3.14%	21,414 $2.07 Million
Q3 2017 Oct 12, 2017	BUY	$69.85 - $89.22 $1.54 Million - $1.97 Million	22,108	22,108 $1.97 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Weaver C. Barksdale & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Weaver C. Barksdale & Associates, Inc. with notifications on news.

Account

Weaver C. Barksdale & Associates, Inc. Abb Vie Inc. Transaction History